Urinary Melatonin Concentration and the Risk of Breast Cancer in Nurses' Health Study II

First-Morning Urinary Melatonin and Breast Cancer Risk in the Guernsey Study

(2014) X.-S. Wang et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Urinary Levels of Melatonin and Risk of Postmenopausal Breast Cancer: Women's Health Initiative Observational Cohort

(2014) S. R. Sturgeon et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A meta-analysis on dose–response relationship between night shift work and the risk of breast cancer

(2013) F. Wang et al.   ANNALS OF ONCOLOGY

Night-shift work and risk of breast cancer: a systematic review and meta-analysis

(2013) Biren B. Kamdar et al.   BREAST CANCER RESEARCH AND TREATMENT

Molecular mechanisms of melatonin’s inhibitory actions on breast cancers

(2012) Sara Proietti et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore

(2012) Anna H. Wu et al.   INTERNATIONAL JOURNAL OF CANCER

Urinary 6-Sulphatoxymelatonin Levels and Risk of Breast Cancer in Premenopausal Women: The ORDET Cohort

(2010) E. S. Schernhammer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses' Health Study Cohort

(2009) E. S. Schernhammer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Molecular Mechanisms of Melatonin Anticancer Effects

(2009) Steven M. Hill et al.   INTEGRATIVE CANCER THERAPIES

Melatonin as a Biomarker of Circadian Dysregulation

(2008) D. K. Mirick et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Circulating melatonin and the risk of breast and endometrial cancer in women

(2008) Akila N. Viswanathan et al.   CANCER LETTERS

Urinary 6-Sulfatoxymelatonin Levels and Risk of Breast Cancer in Postmenopausal Women

(2008) E. S. Schernhammer et al.   JNCI-Journal of the National Cancer Institute